نظرة عامة على البرنامج

Engineering - Pharmaceutical & Biopharmaceutical Engineering

The Part-Time Master of Engineering Science (MEngSc) in Pharmaceutical and Biopharmaceutical Engineering is a unique offering of the discipline of Process and Chemical Engineering designed to provide participants with a formal qualification in areas of particular topical interest to the pharmaceutical and biopharmaceutical industry.

Course Outline

The programme comprises 60 credits of taught modules, comprising both mandatory and elective modules, and 30 credits of a research thesis. Students must take 9 mandatory modules worth 5 credits each to the value of 45 credits. The remaining 3 modules can be selected from a list of 4 modules worth 5 credits each to make up the final 15 credits of the total of 60 credits.

• Year 1, Semester 1 (Mandatory modules)
  • PE6010 Pharmaceutical Engineering (5 credits)
  • PE6011 Biopharmaceutical Engineering (5 credits)
  • PE6013 Powder and Particle Technology and Unit Operations (5 credits)
• Year 1, Semester 2 (Select 3 out of 4 modules)
  • PE6004 Biopharmaceutical Support Systems (5 credits)
  • PE6018 Pharmaceutical Process Validation and Quality (5 credits)
  • PE6019 Process Analytical Technology (5 credits)
  • CM6010 Introductory Pharmaceutical Chemistry (5 credits)
• Year 2, Semester 1 (Mandatory modules)
  • PE6012 Pharmaceutical Process Equipment, Materials and Mechanical Design (5 credits)
  • PE6016 Pharmaceutical Industry: Manufacturing and Optimisation (5 credits)
  • PE6026 Project Engineering - From Concept to Completion (5 credits)
• Year 2, Semester 2 (Mandatory modules)
  • PE6022 Aseptic Manufacturing Design (5 credits)
  • PE6024 Advanced Process Design and Safety Engineering (5 credits)
  • PE6027 Advanced Biopharmaceutical Engineering (5 credits)
• Research Thesis in Pharmaceutical and Biopharmaceutical Engineering (30 credits)

Course Practicalities

The course has been designed to allow working professionals, especially those who are based outside Cork, or even Ireland, to effectively participate in the programme availing of both online materials and in-person lectures facilitating peer-learning and professional networking.

• Attendance Information: The course is scheduled to start with lectures on 12 and 13 September for 2025/2026.
• Assessment: All modules will be assessed via continuous assessment and will consist of live end-of-semester assessments or and online Canvas assignments as per UCC Marks and Standards.
• Who Teaches this Course: This course provides a unique opportunity to learn from academics and industry professionals alike.

Why Choose This Course

The enormous need for Engineers to work in the pharmaceutical, biopharmaceutical and medical devices industries has been well documented in recent years. This course offers you the opportunity to develop an engineering-based understanding of processes and production in a formal manner.

• What are the key learning outcomes: Upon completion of this programme, candidates will be able to apply an enhanced knowledge and understanding of the mathematics, sciences, engineering sciences and technologies to pharmaceutical and biopharmaceutical engineering.
• Placement or Study Abroad Information: There are no structured placement or study abroad opportunities provided directly through programme, however, candidates spend a day at the NIBRT Biopharmaceutical Training Facility in Dublin.

Requirements

Applicants must have a BE (Hons) or BEng (Hons) Degree or equivalent engineering qualification, with a minimum Second-Class Honours Grade II, or a level 8 BSc degree, with a minimum grade Second Class Honours Grade II, where the BSc graduate has a recognised qualification in process or Chemical Engineering.

Fees and Costs

The EU fee for this course is Part-time: 4,700.

How To Apply

1. Check dates: Check the opening and closing dates for the application process.
2. Gather documents: Scanned copies of supporting documents have to be uploaded to the UCC online application portal.
3. Apply online: Apply online by clicking the application portal.